Back to Stakeholders
Categories
2 domains / 4 areas / 2 specializations
NYU Langone Health
United States
11 Trials
Home to the NYU Langone Center for Psychedelic Medicine, one of the world's leading academic institutions in psychedelic research. Has conducted landmark psilocybin trials for smoking cessation, alcohol use disorder, and depression in cancer patients, spearheaded by Dr. Michael Bogenschutz and colleagues.
Academic Research
0 papersPublished Papers
0
Trial Involvement
11
Distinct Focus Topics
0
Latest Publication
Unknown
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit